Mass concentration of protein in serum (observable entity)
| Code | 1107831000000105 |
|---|---|
| Semantic tag | observable entity |
| Module | uk-drug |
| Definition | primitive |
| Effective time | 20210317 |
1032021000000100Protein level
observable entity
12621000237100Adalimumab mass concentration in serum
observable entity
27461000237100Alpha-1 acid glycoprotein mass concentration in serum
observable entity
25281000237104Apolipoprotein A1 mass concentration in serum
observable entity
30261000237101Apolipoprotein A2 mass concentration in serum
observable entity
13161000237109Caeruloplasmin mass concentration in serum
observable entity
11761000237109Golimumab mass concentration in serum
observable entity
12121000237105Haptoglobin mass concentration in serum
observable entity
28211000237102IGFBP-1 (insulin like growth factor binding protein 1) mass concentration in serum
None
31221000237100IGFBP-2 (insulin like growth factor binding protein 2) mass concentration in serum
observable entity
25441000237109IGFBP-3 (insulin like growth factor binding protein 3) mass concentration in serum
observable entity
15991000237104Immunoreactive trypsinogen mass concentration in serum
observable entity
11611000237103Infliximab mass concentration in serum
observable entity
28591000237106Mannose binding lectin mass concentration in serum
observable entity
31571000237104Myoglobin mass concentration in serum
observable entity
15181000237103Neurone specific enolase mass concentration in serum
observable entity
13781000237103Retinol binding protein mass concentration in serum
observable entity
14121000237100Teicoplanin mass concentration in serum
observable entity
30131000237103Ubiquinone mass concentration in serum
observable entity
15301000237108Vancomycin mass concentration in serum
observable entity